Intrinsic Value of S&P & Nasdaq Contact Us

PRF Technologies Ltd. PRFX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
21/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

PRF Technologies Ltd. (PRFX) generated $-991K in operating cash flow for quarter ending 2025-06-30. After capital expenditures of $0.00, free cash flow was $-991K.

Cash conversion ratio was 0.86x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (0/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was 0.86x suggests some earnings are non-cash items

Overall SharesGrow Score: 21/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
21/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
0/100
Proven by this page
GROWTH
30/100
→ Income
INCOME
10/100
→ Income
PRF Technologies Ltd. Cash Flow History
Metric TTM Q2 FY2025 Q1 FY2025 Q4 FY2024 Q3 FY2024
Operating Cash Flow $-5.96M$-991K$-991K$-1.99M$-1.99M
Capital Expenditure $-1K$0.00$0.00$-500.00$-500.00
Free Cash Flow $-5.96M$-991K$-991K$-1.99M$-1.99M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message